oAlert.pl

Medicines & supplements – Current GIS Alerts 2026

Found 762 alerts in the Medicines & supplements category. Check batch numbers, shops, and hazard information.

Common hazards in this category

All recalled products

Recalled product: Verdin Fix composition of 6 herbs

Verdin Fix composition of 6 herbs

GIS Critical 10.07.2026

Testing showed the presence of Salmonella bacteria in two batches of the dietary supplement in sachets for preparing an infusion. Potential effects: foodborne infection, diarrhoea, vomiting, fever.

Recalled product: Loperamid APTEO MED

Loperamid APTEO MED

GIF Medium 09.07.2026

Failure to meet quality requirements consists in exceeding the lower limit of the specification for the "active substance content" parameter, leading to reduced content and a real risk to patients' health due to lack of the intended effectiveness of the medicinal product. Potential effects: lack of treatment efficacy, risk of persistent symptoms.

Recalled product: Docetaxel Accord

Docetaxel Accord

GIF Medium 09.07.2026

Long-term stability studies showed out-of-specification results for related substances - the level of impurity B exceeds the registered quality specification limit. Potential effects: unknown toxicological effects and possible adverse reactions.

Recalled product: Verdin Fix herbal tea blend of 6 herbs

Verdin Fix herbal tea blend of 6 herbs

- Critical 07.07.2026 • Auchan

The product was found to contain Salmonella bacteria, which may lead to foodborne infection after consuming the product from this batch. Potential effects: gastrointestinal symptoms, diarrhoea, vomiting, fever.

Recalled product: Kwas traneksamowy Tillomed

Kwas traneksamowy Tillomed

GIF Critical 02.07.2026

Failure to meet quality requirements was found for the parameter of contamination with particles visible to the naked eye in the solution for injection. Potencjalne skutki: complications after intravenous administration, inflammatory reactions, embolisation by solid particles, lack of treatment safety.

Recalled product: Elenium

Elenium

GIF Medium 29.06.2026

Reasonable suspicion of failure to meet quality requirements - out-of-specification result for the active substance chlordiazepoxide release parameter, which may indicate too low release of the drug from the tablet. Potencjalne skutki: lack of therapeutic effect, persistence or worsening of symptoms, withdrawal complications.

Recalled product: Apiolin

Apiolin

GIF Critical 26.06.2026

This batch was reported due to the risk of exceeding the acceptable daily intake limit for the N-nitroso sertraline impurity (AI 100 ng/day) and the temporary limit of 670 ng/day for long-term treatments. Potencjalne skutki: possible increased carcinogenic risk during long-term use of the medicine.

Recalled product: Levosimendan Farmak

Levosimendan Farmak

GIF Critical 19.06.2026

The product does not meet quality requirements due to contamination with particles visible to the naked eye in the concentrate for solution for infusion. Potential effects: emboli and vessel damage, inflammatory reactions, circulatory complications during intravenous administration of the drug.

Recalled product: Teicoplanin AptaPharma

Teicoplanin AptaPharma

GIF Critical 17.06.2026

Quality testing detected contamination with particles visible to the naked eye in the powder and solvent, so the product after reconstitution does not meet quality requirements for an injectable/infusion solution. Potential effects: complications after parenteral administration, including inflammatory reactions, emboli and lack of treatment safety.

Recalled product: Teicoplanin AptaPharma

Teicoplanin AptaPharma

GIF Critical 17.06.2026

The tested sample did not meet the specification for the parameter "contamination with particles visible to the naked eye"; in 2 out of 20 vials of powder one particle was detected in the reconstituted product, probably originating from the solvent. Potencjalne skutki: embolism after intravenous administration, thrombotic complications, inflammatory reactions.

Recalled product: Azaneson

Azaneson

GIF Medium 17.06.2026

The tested sample of the product does not meet the requirement for chromatographic purity. The presence of a single impurity and total impurities exceeding the quality specification limit for this product was confirmed. Potencjalne skutki: reduced medicine quality, possible adverse effects or lack of expected efficacy.

Recalled product: Imuldosa

Imuldosa

GIF Critical 03.06.2026

Non-compliances identified at the manufacturer, including deficiencies in assessment of packaging quality, contamination control and aseptic techniques, may affect key quality parameters, including the sterility of the medicinal product. Potential effects: infections, lack of therapeutic efficacy, serious adverse reactions.

Recalled product: Loperamid APTEO MED

Loperamid APTEO MED

GIF Low 03.06.2026

Out-of-specification (OOS) results were found for the "active substance content" parameter during stability testing of selected batches of Loperamide APTEO MED 2 mg, raising justified doubts as to whether they meet quality requirements. Potential effects: lack of efficacy in diarrhoea treatment.

Recalled product: Tullex

Tullex

GIF Critical 02.06.2026

Out-of-specification result in long-term stability testing: during the sterility test microbial growth was observed in a batch of the product, indicating potential microbiological contamination of the solution for injection. Potencjalne skutki: infection after administration of the drug, including severe systemic infections.

Recalled product: Travoprost + Timolol Medical Valley

Travoprost + Timolol Medical Valley

GIF High 02.06.2026

Testing by NIL revealed leaking bottles and exceeding the limit for travoprost-related substances - each unknown impurity was above 1.5 times the upper acceptance limit. Potencjalne skutki: eye infections, irritation, lack of effectiveness in glaucoma treatment.

Recalled product: Kidofen

Kidofen

GIF Medium 01.06.2026

Failure to meet quality requirements: exceeding the specification limit for the parameter "Impurities - each single impurity" in stability studies of batch 01AF1024, which may affect the efficacy and safety of the medicine used in children. Potential effects: possible toxic effects and impaired safety or efficacy of therapy.

Recalled product: Teikoplanina BRADEX

Teikoplanina BRADEX

GIF Critical 28.05.2026

Tests by the National Medicines Institute showed failure to meet specification requirements for subvisible particulate contamination (negative result for particles ≥10 μm) and non-compliance of the reconstituted solution appearance with the registration dossier. Potential effects: complications after intravenous administration, local reactions, risk to treatment safety.

Recalled product: Dietary supplement Verdin Fix Composition of 6 herbs, 20 sachets (36 g)

Dietary supplement Verdin Fix Composition of 6 herbs, 20 sachets (36 g)

GIS Critical 27.05.2026

Official control detected Salmonella spp. bacteria in one of five samples of this dietary supplement, which may pose a health risk to consumers, especially if Salmonella is transferred to other surfaces. Potential effects: food poisoning, gastrointestinal infection.

Recalled product: VERDIN Fix Herbal tea blend of 6 herbs 20 sachets 36 g (20 x 1.8 g)

VERDIN Fix Herbal tea blend of 6 herbs 20 sachets 36 g (20 x 1.8 g)

- High 25.05.2026 • Auchan

The product has been withdrawn due to a potential risk of microbiological contamination, reported by the supplier. The actions are preventive and carried out in cooperation with the supplier. Potential effects: foodborne infections, gastrointestinal discomfort.

Recalled product: Fresh Bomb Sweet Strawberry Strong+, 100 ml

Fresh Bomb Sweet Strawberry Strong+, 100 ml

GIS High 22.05.2026

The food supplements were found to contain the psychoactive substance tetrahydrocannabinol (THC), which violates regulations and may endanger consumers' health. Potencjalne skutki: impaired consciousness, anxiety, drowsiness, dizziness, other psychoactive effects.

What to do if you bought a recalled product?

If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.